查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1403405

到 2030 年藥品無菌檢測市場預測：按產品、檢測類型、服務、應用、最終用戶和地區進行的全球分析

Pharmaceutical Sterility Testing Market Forecasts to 2030 - Global Analysis By Product, Test Type, Service, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球藥品無菌檢測市場規模為 16.1 億美元，預計在預測期內將以 13.4% 的複合年成長率成長，到 2030 年達到 38.8 億美元。

藥品的無菌測試是一個重要的品管過程，可確保藥品和醫療產品中不存在活微生物。它在嚴格的無菌條件下進行，檢驗批次無菌性並防止可能危及患者安全的污染。此測試通常使用薄膜過濾或直接接種方法進行，符合 USP 和 EP 等監管標準。

根據2021-2022年美國聯邦預算，印度科技部向DBT（生物技術部）撥款4.3億美元，較2020-2021年預算增加25%。

成長動力：醫藥供應鏈全球化

藥品供應鏈的全球化顯著增加了原料和製造流程的國際採購，增加了嚴格的無菌測試協議以確保產品安全和監管合規性的重要性。隨著供應鏈的相互連結日益緊密，對強大的無菌檢測解決方案的需求不斷增加，推動了藥品無菌檢測市場的成長，成為在全球範圍內保持藥品完整性的關鍵要素。

成長抑制因素：時間和經濟限制

由於測試過程的複雜性，藥品無菌測試公司面臨時間和財務限制。嚴格的程序對於確保產品符合監管標準至關重要。時間限制是由於需要在有限的生產計劃內獲得準確的結果而產生的，並影響整體效率。經濟壓力來自於維持無菌環境、專業設備和僱用熟練人員的高成本。因此，這方面阻礙了市場的擴大。

機會：外包檢驗服務

隨著製藥公司尋求成本效率、法規遵循和縮短時間，外包無菌檢測使他們能夠利用專業知識、先進技術和專用設施。這一趨勢使公司能夠簡化業務、減輕內部測試負擔並確保嚴格的品質標準。隨著對無菌保證的日益重視，檢測服務外包已成為製藥公司的策略解決方案，推動市場成長和創新。

威脅：快速演化的病原體

藥品的無菌檢測面臨快速進化的病原體的威脅，其性能優於傳統的檢測方法。隨著病原體的進化，它們對現有滅菌方法的抵抗力更強，可能會損害藥物安全。快速突變率、水平基因轉移和新出現的菌株增加了未檢測到污染物的風險。傳統的無菌檢測無法跟上這些病原體的動態特性，這可能對確保藥物功效構成挑戰。

COVID-19 的影響

COVID-19大流行對藥品無菌檢測市場產生了重大影響。對藥品（包括疫苗和治療藥物）的需求增加，增加了對嚴格無菌測試的需求。這促使企業專注於確保其產品的安全性和有效性，市場迅速成長。此外，這場大流行凸顯了在藥品製造過程中保持無菌的重要性，導致人們更加重視先進的無菌測試技術和方法，以滿足監管標準並應對新的醫療保健挑戰。

快速微測試產業預計在預測期內規模最大

與傳統方法相比，快速微測試領域由於其快速的結果預計將出現良好的成長。這些測試採用聚合酶連鎖反應 (PCR) 或螢光技術等先進技術，可快速檢測藥品中的微生物污染。快速微量測試的實施提高了效率，減少了測試時間，確保無菌產品快速上市，並最終有助於改善藥品製造流程和法規遵循。

預計無菌製藥業在預測期內複合年成長率最高

由於其品質保證和長期成本降低，無菌製藥行業預計在預測期內將出現最高的複合年成長率。藥品的無菌測試對於確保無菌藥品不含有害微生物非常重要。這個嚴格的製程評估產品批次是否有細菌、真菌和病毒。這個過程提高了製藥公司的聲譽，降低了產品召回的可能性，並最終有助於無菌藥物生產的整體完整性和可靠性。

比最大的地區

預計亞太地區在預測期內將佔據最大的市場佔有率。中國可望在藥品無菌檢測領域佔有重要地位。該地區的新興國家正採取各種措施擴大國內醫藥市場，吸引跨國公司在本國開展業務。此外，印度對藥品的高額投資使其能夠製造醫療設備並進行廣泛的無菌測試。此外，預算增加、生物技術研發增加以及該地區工業和創業發展等因素正在推動市場成長。

複合年成長率最高的地區

預計北美在預測期內的複合年成長率最高。該地區的製藥業有大有小，檢測需求多樣。快速發展的技術和對創新的重視正在影響產業的無菌檢測方法，帶來機會和挑戰。北美各地的地理和監管多樣性正在進一步影響製藥公司的測試實踐和合規策略。此外，該地區許多主要市場相關人員的存在預計將為市場成長做出重大貢獻。

免費客製化服務：

訂閱此報告的客戶可以利用以下免費自訂選項之一：

  • 公司簡介
    • 其他市場公司的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 公司之間的競爭關係

第5章全球藥品無菌檢測市場：依產品

  • 用具
  • 套件和試劑

第6章全球藥品無菌檢測市場：依測試類型

  • 容器密閉完整性測試
  • 無菌測試
    • 薄膜過濾
    • 直接接種
  • 細菌內毒素檢查
  • 螢光標記
  • 快速微量測試
    • 生物負載測試
    • ATP生物發光
    • 電阻
  • 其他測試類型

第7章全球藥品無菌檢測市場：依服務分類

  • 公司內部
  • 委託

第8章全球藥品無菌檢測市場：依應用分類

  • 無菌藥物
  • 生技藥品和治療學
  • 醫療設備

第9章全球藥品無菌檢測市場：依最終用戶分類

  • 配藥房
  • 醫療設備公司
  • 製藥公司
  • 其他最終用戶

第10章全球藥品無菌檢測市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第11章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司簡介

  • Nelson Laboratories LLC
  • Laboratory Corporation of America Holding
  • Pacific BioLabs
  • Pace Analytical
  • Charles River Laboratories
  • Thermo Fisher Scientific Inc
  • STEMart
  • Boston Analytical
  • Almac Group
  • Solvias AG
  • Redberry-Rapid Microbiology
  • Rapid Micro Biosystems
  • Sartorius AG
  • Intertek
  • BioScreen Testing Services Inc.
  • WuXi AppTec
  • Microbac Laboratories
  • NSF International
  • Eurofins Scientific
Product Code: SMRC24630

According to Stratistics MRC, the Global Pharmaceutical Sterility Testing Market is accounted for $1.61 billion in 2023 and is expected to reach $3.88 billion by 2030 growing at a CAGR of 13.4% during the forecast period. Pharmaceutical sterility testing is a crucial quality control process ensuring the absence of viable microorganisms in drugs and medical products. Conducted under strict aseptic conditions, it verifies the sterility of batches, preventing contamination that could compromise patient safety. Commonly performed using membrane filtration or direct inoculation methods, this testing adheres to regulatory standards such as USP or EP.

According to the Union Budget for the years 2021 to 2022, the Indian Ministry of Science and Technology allocated US$ 430 million, a 25% increase from the budget for the years 2020 to 2021, for the DBT (Department of Biotechnology).

Market Dynamics:

Driver:

Globalization of pharmaceutical supply chains

The globalization of pharmaceutical supply chains has significantly increased international sourcing of raw materials and manufacturing processes which has heightened the importance of stringent sterility testing protocols to ensure product safety and regulatory compliance. As supply chains become more interconnected, the demand for robust sterility testing solutions has risen, driving the growth of the pharmaceutical sterility testing market as a critical component in maintaining the integrity of pharmaceutical products on a global scale.

Restraint:

Time & financial constraints

Pharmaceutical sterility testing companies face time and financial constraints due to the intricate nature of the testing process. Rigorous procedures are essential to ensure products meet regulatory standards. Time constraints arise from the need for accurate results within limited production timelines, affecting overall efficiency. Financial pressures stem from the high costs associated with maintaining sterile environments, specialized equipment, and employing skilled personnel. Thereby, this aspect impedes the market from expansion.

Opportunity:

Outsourcing of testing services

As pharmaceutical companies strive for cost efficiency, regulatory compliance, and faster time-to-market, outsourcing sterile testing allows them to leverage specialized expertise, advanced technologies, and dedicated facilities. This trend enables businesses to streamline operations, reduce in-house testing burdens, and ensure stringent quality standards. With the increasing emphasis on sterility assurance, outsourcing testing services emerges as a strategic solution for pharmaceutical companies, fostering growth and innovation in the market.

Threat:

Rapidly evolving pathogens

Pharmaceutical sterility testing faces a threat from rapidly evolving pathogens due to their ability to outpace traditional testing methodologies. As pathogens evolve, their resistance to existing sterilization methods increases, potentially compromising drug safety. Rapid mutation rates, horizontal gene transfer, and emerging strains heighten the risk of undetected contaminants. Conventional sterility tests may struggle to keep pace with the dynamic nature of these pathogens, posing challenges in ensuring the efficacy of pharmaceutical products.

COVID-19 Impact

The COVID-19 pandemic has significantly impacted the pharmaceutical sterility testing market. The increased demand for pharmaceutical products, including vaccines and therapeutics, has driven the need for rigorous sterility testing. This has led to a surge in market growth as companies focus on ensuring the safety and efficacy of their products. Additionally, the pandemic has highlighted the importance of maintaining sterility in pharmaceutical manufacturing processes, resulting in greater emphasis on advanced sterility testing technologies and methods to meet regulatory standards and address emerging healthcare challenges.

The rapid micro test segment is expected to be the largest during the forecast period

The rapid micro test segment is estimated to have a lucrative growth, due to its quicker results compared to traditional methods. These tests employ advanced technologies, such as polymerase chain reaction (PCR) or fluorescence-based techniques, enabling swift detection of microbial contamination in pharmaceutical products. The implementation of Rapid Micro Tests enhances efficiency, reduces testing time, and ensures faster release of sterile products to the market, ultimately contributing to improved pharmaceutical manufacturing processes and regulatory compliance.

The sterile drugs segment is expected to have the highest CAGR during the forecast period

The sterile drugs segment is anticipated to witness the highest CAGR growth during the forecast period, due to its quality assurance and long term cost savings. Pharmaceutical Sterility Testing is critical for sterile drugs to ensure they are free from harmful microorganisms. This rigorous process involves assessing product batches for bacterial, fungal, or viral contamination. This process enhances pharmaceutical companies' reputation, reduces the likelihood of product recalls, and ultimately contributes to the overall integrity and reliability of sterile drug manufacturing.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period. China is anticipated to hold a significant rank in the pharmaceutical sterility testing sector. The region's emerging economies are taking diversed steps to expand their domestic pharmaceutical market and are enticing multinational corporations to establish operations in their nation. Additionally, India is prepared to manufacture medical devices and conduct extensive sterility testing due to its substantial pharmaceutical investment. Further, factors such as increase in budget, rise in biotechnology R&D, as well as industrial and entrepreneurship development in the region are boosting the market growth.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period. The region's diverse pharmaceutical landscape, encompassing large & small-scale manufacturers, contributes to varied testing needs. Rapidly evolving technologies and an emphasis on innovation present both opportunities and challenges, influencing the industry's approach to sterility testing. The geographic and regulatory diversity across North America further shapes testing methodologies and compliance strategies for pharmaceutical companies. Also, the presence of a large number of major market players in this region is expected to contribute significantly to the market growth.

Key players in the market:

Some of the key players profiled in the Pharmaceutical Sterility Testing Market include Nelson Laboratories LLC, Laboratory Corporation of America Holding, Pacific BioLabs, Pace Analytical, Charles River Laboratories, Thermo Fisher Scientific Inc, STEMart, Boston Analytical, Almac Group, Solvias AG, Redberry - Rapid Microbiology, Rapid Micro Biosystems, Sartorius AG, Intertek, BioScreen Testing Services Inc., WuXi AppTec, Microbac Laboratories, NSF International and Eurofins Scientific.

Key Developments:

In April 2023, STEMart, a U.S.-based provider of comprehensive services for all stages of medical device development, has introduced the Bioburden and Sterility Testing services for medical devices under the guidance of the ISO 11731 method. With extensive expertise in microbiology and sterility testing, STEMart can provide comprehensive services to support manufacturers in meeting regulatory goals and minimizing compliance risks.

In January 2023, Thermo Fisher Scientific, the world leader in serving science, is opening a new facility in Hangzhou, China, as part of its global effort to help companies provide therapies to patients more quickly. The site can address the needs of organizations in China, as well as those outside that country, for biologics and steriles development and manufacturing capabilities in the Asia-Pacific region.

Products Covered:

  • Instruments
  • Kits & Reagents

Test Types Covered:

  • Container Closure Integrity Testing
  • Sterility Testing
  • Bacterial Endotoxin Testing
  • Fluorescent Labeling
  • Rapid Micro Test
  • Other Test Types

Services Covered:

  • In-House
  • Outsourced

Applications Covered:

  • Sterile Drugs
  • Biologics & Therapeutics
  • Medical Devices

End Users Covered:

  • Compounding Pharmacies
  • Medical Devices Companies
  • Pharmaceutical Companies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Pharmaceutical Sterility Testing Market, By Product

  • 5.1 Introduction
  • 5.2 Instruments
  • 5.3 Kits & Reagents

6 Global Pharmaceutical Sterility Testing Market, By Test Type

  • 6.1 Introduction
  • 6.2 Container Closure Integrity Testing
  • 6.3 Sterility Testing
    • 6.3.1 Membrane Filtration
    • 6.3.2 Direct Inoculation
  • 6.4 Bacterial Endotoxin Testing
  • 6.5 Fluorescent Labeling
  • 6.6 Rapid Micro Test
    • 6.6.1 Bioburden Testing
    • 6.6.2 ATP Bioluminescence
    • 6.6.3 Electrical Resistance
  • 6.7 Other Test Types

7 Global Pharmaceutical Sterility Testing Market, By Service

  • 7.1 Introduction
  • 7.2 In-House
  • 7.3 Outsourced

8 Global Pharmaceutical Sterility Testing Market, By Application

  • 8.1 Introduction
  • 8.2 Sterile Drugs
  • 8.3 Biologics & Therapeutics
  • 8.4 Medical Devices

9 Global Pharmaceutical Sterility Testing Market, By End User

  • 9.1 Introduction
  • 9.2 Compounding Pharmacies
  • 9.3 Medical Devices Companies
  • 9.4 Pharmaceutical Companies
  • 9.5 Other End Users

10 Global Pharmaceutical Sterility Testing Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Nelson Laboratories LLC
  • 12.2 Laboratory Corporation of America Holding
  • 12.3 Pacific BioLabs
  • 12.4 Pace Analytical
  • 12.5 Charles River Laboratories
  • 12.6 Thermo Fisher Scientific Inc
  • 12.7 STEMart
  • 12.8 Boston Analytical
  • 12.9 Almac Group
  • 12.10 Solvias AG
  • 12.11 Redberry - Rapid Microbiology
  • 12.12 Rapid Micro Biosystems
  • 12.13 Sartorius AG
  • 12.14 Intertek
  • 12.15 BioScreen Testing Services Inc.
  • 12.16 WuXi AppTec
  • 12.17 Microbac Laboratories
  • 12.18 NSF International
  • 12.19 Eurofins Scientific

List of Tables

  • Table 1 Global Pharmaceutical Sterility Testing Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Pharmaceutical Sterility Testing Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Pharmaceutical Sterility Testing Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 4 Global Pharmaceutical Sterility Testing Market Outlook, By Kits & Reagents (2021-2030) ($MN)
  • Table 5 Global Pharmaceutical Sterility Testing Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 6 Global Pharmaceutical Sterility Testing Market Outlook, By Container Closure Integrity Testing (2021-2030) ($MN)
  • Table 7 Global Pharmaceutical Sterility Testing Market Outlook, By Sterility Testing (2021-2030) ($MN)
  • Table 8 Global Pharmaceutical Sterility Testing Market Outlook, By Membrane Filtration (2021-2030) ($MN)
  • Table 9 Global Pharmaceutical Sterility Testing Market Outlook, By Direct Inoculation (2021-2030) ($MN)
  • Table 10 Global Pharmaceutical Sterility Testing Market Outlook, By Bacterial Endotoxin Testing (2021-2030) ($MN)
  • Table 11 Global Pharmaceutical Sterility Testing Market Outlook, By Fluorescent Labeling (2021-2030) ($MN)
  • Table 12 Global Pharmaceutical Sterility Testing Market Outlook, By Rapid Micro Test (2021-2030) ($MN)
  • Table 13 Global Pharmaceutical Sterility Testing Market Outlook, By Bioburden Testing (2021-2030) ($MN)
  • Table 14 Global Pharmaceutical Sterility Testing Market Outlook, By ATP Bioluminescence (2021-2030) ($MN)
  • Table 15 Global Pharmaceutical Sterility Testing Market Outlook, By Electrical Resistance (2021-2030) ($MN)
  • Table 16 Global Pharmaceutical Sterility Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 17 Global Pharmaceutical Sterility Testing Market Outlook, By Service (2021-2030) ($MN)
  • Table 18 Global Pharmaceutical Sterility Testing Market Outlook, By In-House (2021-2030) ($MN)
  • Table 19 Global Pharmaceutical Sterility Testing Market Outlook, By Outsourced (2021-2030) ($MN)
  • Table 20 Global Pharmaceutical Sterility Testing Market Outlook, By Application (2021-2030) ($MN)
  • Table 21 Global Pharmaceutical Sterility Testing Market Outlook, By Sterile Drugs (2021-2030) ($MN)
  • Table 22 Global Pharmaceutical Sterility Testing Market Outlook, By Biologics & Therapeutics (2021-2030) ($MN)
  • Table 23 Global Pharmaceutical Sterility Testing Market Outlook, By Medical Devices (2021-2030) ($MN)
  • Table 24 Global Pharmaceutical Sterility Testing Market Outlook, By End User (2021-2030) ($MN)
  • Table 25 Global Pharmaceutical Sterility Testing Market Outlook, By Compounding Pharmacies (2021-2030) ($MN)
  • Table 26 Global Pharmaceutical Sterility Testing Market Outlook, By Medical Devices Companies (2021-2030) ($MN)
  • Table 27 Global Pharmaceutical Sterility Testing Market Outlook, By Pharmaceutical Companies (2021-2030) ($MN)
  • Table 28 Global Pharmaceutical Sterility Testing Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.